Immunology, Acquired immunodeficiency syndrome, Virology, Internal medicine and Pediatrics are her primary areas of study. Her study focuses on the intersection of Immunology and fields such as Transmission with connections in the field of Reverse-transcriptase inhibitor. Glenda Gray interconnects Psychological intervention and Socioeconomic status in the investigation of issues within Acquired immunodeficiency syndrome.
Her work on Lentivirus as part of general Virology research is often related to Ctl epitope, thus linking different fields of science. The various areas that Glenda Gray examines in her Internal medicine study include Placebo and Oncology. The concepts of her Clinical trial study are interwoven with issues in HIV vaccine and Tolerability.
Glenda Gray mostly deals with Immunology, Acquired immunodeficiency syndrome, Internal medicine, Virology and HIV vaccine. Her Immunology study which covers Transmission that intersects with Pediatrics, Intervention and Drug resistance. As part of the same scientific family, Glenda Gray usually focuses on Acquired immunodeficiency syndrome, concentrating on Psychological intervention and intersecting with Young adult and Reproductive health.
Her work carried out in the field of Internal medicine brings together such families of science as Cross-sectional study and Placebo. Glenda Gray works in the field of Virology, namely Virus. Her HIV vaccine research includes themes of Clinical trial, Family medicine, Vaccine efficacy, Vaccination and MF59.
Her primary areas of study are HIV vaccine, Internal medicine, Young adult, Vaccination and Family medicine. Her HIV vaccine study also includes fields such as
In her research, Interpersonal relationship is intimately related to Reproductive health, which falls under the overarching field of Young adult. Her Family medicine research is multidisciplinary, incorporating elements of Psychological intervention, Condom and Partner notification. Her Antibody study combines topics from a wide range of disciplines, such as Clinical trial and Virology.
Her primary scientific interests are in HIV vaccine, Vaccination, Immunology, Antibody and Virology. She has included themes like Public health, AIDS Vaccines, MEDLINE and Family medicine in her HIV vaccine study. Glenda Gray combines subjects such as Regimen, Economic evaluation, Incidence and Environmental health with her study of Vaccination.
Her Regimen study integrates concerns from other disciplines, such as Adverse effect, Placebo, Not evaluated and Randomized controlled trial. Her study connects Young adult and Immunology. Her research integrates issues of Multiplex, Canarypox, Epitope, Linear epitope and Immunogen in her study of Virology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
C. Celum;A. Wald;A. Wald;J.R. Lingappa;A.S. Magaret;A.S. Magaret.
The New England Journal of Medicine (2010)
Prevalence and Patterns of Gender-based Violence and Revictimization among Women Attending Antenatal Clinics in Soweto, South Africa
Kristin L. Dunkle;Rachel K. Jewkes;Heather C. Brown;Mieko Yoshihama.
American Journal of Epidemiology (2004)
Community-based intervention to increase HIV testing and case detection in people aged 16–32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study
Michael Sweat;Stephen Morin;David Celentano;Marta Mulawa.
Lancet Infectious Diseases (2011)
Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
Jonathan E Golub;Paul Pronyk;Paul Pronyk;Lerato Mohapi;Nkeko Thsabangu.
International Seroepidemiology of Adenovirus Serotypes 5, 26, 35, and 48 in Pediatric and Adult Populations
Dan H. Barouch;Dan H. Barouch;Sandra V. Kik;Gerrit J. Weverling;Rebecca Dilan.
Emergence of Drug-Resistant HIV-1 after Intrapartum Administration of Single-Dose Nevirapine Is Substantially Underestimated
Jeffrey A. Johnson;Jin Fen Li;Lynn Morris;Neil Martinson.
The Journal of Infectious Diseases (2005)
Hierarchical Targeting of Subtype C Human Immunodeficiency Virus Type 1 Proteins by CD8+ T Cells: Correlation with Viral Load
Agatha Masemola;Tumelo Mashishi;Greg Khoury;Phineas Mohube.
Journal of Virology (2004)
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
Dan H Barouch;Dan H Barouch;Frank L Tomaka;Frank Wegmann;Daniel J Stieh.
The Lancet (2018)
The NEAT study: a 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients.
Amalia Rodriguez-French;Jack Boghossian;Glenda E Gray;Jeffrey P Nadler.
Journal of Acquired Immune Deficiency Syndromes (2004)
Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.
Jairam R Lingappa;Jared M Baeten;Anna Wald;James P Hughes.
The Lancet (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: